Silencing of peroxiredoxin 3 and peroxiredoxin 5 reveals the role of mitochondrial peroxiredoxins in the protection of human neuroblastoma SH-SY5Y cells toward MPP+.
Peroxiredoxins (PRDXs) are a family of peroxidases well conserved throughout evolution. Human PRDX3 and PRDX5, two mitochondrial PRDXs, have been implicated in several pathologies associated with oxidative stress. However, the individual role of PRDX3 and PRDX5 in cellular antioxidant defense has never been well established due to their overlapping peroxidatic activities. We investigated the expression and function of mitochondrial PRDXs in human neuroblastoma SH-SY5Y cells. Our results show that PRDX3 and PRDX5 are expressed constitutively in these neuronal cells. To examine further the function of mitochondrial PRDXs, we silenced the expression of PRDX3 and/or PRDX5 using small hairpin RNAs. Our results show that mitochondrial PRDX-depleted cells are more prone to oxidative damages and apoptosis induced by MPP(+), a complex I inhibitor which provides an experimental paradigm of Parkinson's disease.
De Simoni
Stéphanie
S
Laboratory of Cell Biology, Institut des Sciences de la Vie, Université catholique de Louvain, 5 Place Croix du Sud, 1348 Louvain-la-Neuve, Belgium.
Goemaere
Julie
J
Knoops
Bernard
B
D015655:1-Methyl-4-phenylpyridinium / Q000633:toxicity; D017209:Apoptosis / Q000187:drug effects / Q000235:genetics; D002470:Cell Survival / Q000187:drug effects / Q000235:genetics; D019610:Cytoprotection / Q000187:drug effects / Q000235:genetics*; D015536:Down-Regulation / Q000235:genetics; D045222:Electron Transport Chain Complex Proteins / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D004734:Energy Metabolism / Q000187:drug effects / Q000235:genetics; D020868:Gene Silencing / Q000502:physiology; D006801:Humans; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism*; D009447:Neuroblastoma; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D009498:Neurotoxins / Q000633:toxicity; D018384:Oxidative Stress / Q000187:drug effects / Q000235:genetics; D061105:Peroxiredoxin III; D054464:Peroxiredoxins / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D034741:RNA, Small Interfering / Q000235:genetics; D013378:Substantia Nigra / Q000187:drug effects / Q000378:metabolism* / Q000503:physiopathology; D014407:Tumor Cells, Cultured
D045222:Electron Transport Chain Complex Proteins; D009498:Neurotoxins; D034741:RNA, Small Interfering; C516115:PRDX3 protein, human; C515974:PRDX5 protein, human; D061105:Peroxiredoxin III; D054464:Peroxiredoxins; D015655:1-Methyl-4-phenylpyridinium